Novel coronavirus pneumonia is attracting attention in the European Union

Concerns have been raised in Europe about the effectiveness of the treatment of COVID-19

The publication of the paper attracted wide attention in Europe.

The study adopts prospective, non-blinded, randomized controlled, multi-center research methods to evaluate whether the addition of Lianhua Qingwen Capsules on the basis of conventional treatment can enable patients to obtain better clinical efficacy. The test data of this study was analyzed by a professional third party. The results showed that the Lianhua Qingwen treatment group significantly improved the disappearance rate of main clinical symptoms (fever, fatigue, cough) after 14 days of treatment, reaching 57.7% of treatment for 7 days and 80.3 for 10 days of treatment. %, 91.5% after 14 days of treatment. The duration of individual symptoms of fever, fatigue, and cough was also significantly shortened. At the same time, the Lianhua Qingwen treatment group significantly improved the lung CT imaging characteristics. Regarding the nucleic acid negative rate and time of new coronary pneumonia, the nucleic acid negative rate of the treatment group after 14 days of treatment with Lianhua Qingwen Capsule was 76.8%, and the negative time was 11 days, showing a certain trend compared with the control group. Compared with the conventional treatment group, the reduction of the proportion of severe transformation was reduced by 50% (the proportion of severe transformation in the Lianhua Qingwen treatment group was 2.1%, and the conventional treatment group 4.2%). This shows that the application of Lianhua Qingwen for 14 days on the basis of conventional treatment can significantly increase the disappearance rate of clinical symptoms such as fever, fatigue, and cough of new coronary pneumonia, significantly improve lung imaging characteristics, and shorten the duration of symptoms. This shows that Lianhua Qingwen Capsules can improve clinical symptoms and improve clinical outcomes when used in the treatment of patients with new coronary pneumonia. The paper also pointed out that the clinical research results not only confirmed that Lianhua Qingwen Capsules can improve the clinical symptoms and clinical outcomes of patie